| Literature DB >> 29492213 |
Hye Jin Kang1, Dae Won Jun1, Seung Min Lee2, Eun Chul Jang3, Yong Kyun Cho4.
Abstract
BACKGROUND: Recent several observational studies have reported that high salt intake is associated with obesity. But it is unclear whether salt intake itself induce obesity or low salt diet can reduce body fat mass. We investigated whether a low salt diet can reduce body weight and fat amount. MATRIALS AND METHODS: The randomized, open-label pilot trial was conducted at a single institution. A total of 85 obese people were enrolled. All participants were served meals three times a day, and provided either a low salt diet or control diet with same calorie. Visceral fat was measured with abdominal computer tomography, while body fat mass and total body water was measured with bio-impedance.Entities:
Keywords: diet; low salt; obesity
Year: 2018 PMID: 29492213 PMCID: PMC5823556 DOI: 10.18632/oncotarget.23959
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Baseline characteristics of study participants
| Control group | Low salt group | ||
|---|---|---|---|
| Age (year) | 42.3 ± 7.3 | 42.5 ± 7.6 | 0.881 |
| Height (cm) | 161.0 ± 6.8 | 161.4 ± 8.1 | 0.823 |
| Body weight (kg) | 73.9 ± 8.9 | 74.8 ± 12.7 | 0.700 |
| Body mass index (kg/m2) | 28.4 ± 2.4 | 28.6 ± 3.7 | 0.781 |
| Waist circumference (cm) | 96.9 ± 6.1 | 95.8 ± 7.7 | 0.467 |
| Total abdominal fat area | 394.7 ± 83.3 | 399.0 ± 112.7 | 0.845 |
| Visceral fat area | 143.8 ± 50.7 | 145.7 ± 56.9 | 0.872 |
| Systolic blood pressure (mmHg) | 128.4 ± 15.7 | 129.5 ± 15.1 | 0.762 |
| Diastolic blood pressure (mmHg) | 76.8 ± 10.1 | 74.9 ± 8.3 | 0.373 |
| ALT (U/L) | 25.2 ± 25.9 | 20.4 ± 10.4 | 0.278 |
| AST (U/L) | 21.8 ± 10.1 | 21.8 ± 6.3 | 0.979 |
| γ-GGT (U/L) | 45.9 ± 83.8 | 30.6 ± 30.0 | 0.280 |
| Fasting glucose (mg/dl) | 86.5 ± 16.6 | 82.8 ± 21.0 | 0.381 |
| Triglyceride (mg/dl) | 154.2 ± 88.1 | 154.0 ± 114.6 | 0.993 |
| HDL-cholesterol (mg/dl) | 50.0 ± 11.0 | 53.3 ± 11.9 | 0.208 |
| Fasting insulin (μIU/m) | 6.4 ± 3.6 | 6.7 ± 4.2 | 0.789 |
| HOMA-IR | 25.5 ± 18.5 | 25.7 ± 22.7 | 0.960 |
| Skeletal muscle mass (kg) | 43.2 ± 7.0 | 43.8 ± 9.1 | 0.142 |
| Body fat mass (kg) | 27.2 ± 5.8 | 27.8 ± 8.0 | 0.132 |
| Intracellular water (ℓ) | 20.8 ± 3.5 | 21.3 ± 4.1 | 0.288. |
| Extracellular water (ℓ) | 12.8 ± 2.0 | 13.1 ± 2.6 | 0.096 |
| Total body water (ℓ) | 33.7 ± 5.4 | 34.5 ± 6.7 | 0.193 |
| CT-scan Visceral fat area | 143.8 ± 49.6 | 146.3 ± 56.3 | 0.942 |
| CT-scan Intra-abdominal fat area | 396.9 ± 84.4 | 397.1 ± 111.9 | 0.137 |
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; γ-GGT: γ-glutamyl trasnferase; TG: Triglyceride; HDL-cholesterol: High density lipoprotein cholesterol; HOMA-IR: Homeostatic model assessment - insulin resistance; CT-scan: Computer tomography scan (*p < 0.05 by Student t test between control and low salt group).
Comparison of total body weight, body composition in control and low salt group after 2 months
| Control group | Low salt group | Change rate (%) compare to baseline | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | 2 month | * | Baseline | 2 month | * | Control | Low salt | ** | |
| Body weight change (kg) | 74.1 ± 8.9 | 70.3 ± 8.7 | < 0.001 | 75.1 ± 12.7 | 70.3 ± 12.6 | < 0.001 | |||
| 28.6 ± 2.5 | 27.1 ± 2.5 | < 0.001 | 28.6 ± 3.7 | 26.7 ± 3.8 | < 0.001 | ||||
| Waist circumference (cm) | 97.0 ± 6.4 | 89.6 ± 7.7 | < 0.001 | 95.9 ± 7.6 | 88.0 ± 8.7 | < 0.001 | –7.4 ± 4.7 | –7.9 ± 3.8 | 0.60 |
| Skeletal muscle mass change (kg) | 43.5 ± 7.0 | 43.2 ± 6.8 | 0.154 | 43.4 ± 8.9 | 42.9 ± 8.0 | 0.643 | 0.5 ± 2.6 | 0.1 ± 11.3 | 0.83 |
| Body fat mass change (kg) | 26.6 ± 5.5 | 23.5 ± 5.1 | < 0.001 | 28.1 ± 8.0 | 24.5 ± 8.1 | < 0.001 | –11.0 ± 7.7 | –12.6 ± 8.7 | 0.39 |
| Intracellular water change (ℓ) | 20.9 ± 3.5 | 20.8 ± 3.5 | 0.121 | 21.4 ± 4.1 | 20.7 ± 3.9 | 0.001 | –0.6 ± 2.7 | –2.0 ± 4.0 | 0.07 |
| 12.8 ± 2.0 | 12.8 ± 1.9 | 0.597 | 13.0 ± 2.5 | 12.7 ± 2.4 | 0.006 | ||||
| 33.9 ± 5.4 | 33.7 ± 5.3 | 0.217 | 34.2 ± 6.5 | 33.7 ± 6.3 | 0.001 | ||||
| CT-scan Visceral fat area (cm2) | 143.8 ± 50.7 | 121.1 ± 40.4 | 0.872 | 145.7 ± 56.9 | 115.7 ± 43.2 | 0.573 | –20.6 ± 23.2 | –30.5 ± 26.0 | 0.08 |
| CT-scan Intra-abdominal fat area (cm2) | 394.7 ± 83.3 | 352.2 ± 86.7 | 0.845 | 399.0 ± 112.7 | 344.9 ± 117.2 | 0.758 | –44.3 ± 33.6 | –53.4 ± 46.2 | 0.32 |
BMI: body mass index; CT-scan: Computer tomography scan (*p < 0.05 by paired t test, **p < 0.05 by Student t test).
Figure 1Comparison of total body weight, body composition in low salt and control group after 2 months (* p < 0.05 by Student t test between control and low salt group)
Comparison of metabolic parameter change in control and low salt group
| Control group | Low salt group | Mean difference | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | 2 month | * | Baseline | 2 month | * | Control | Low salt | ** | |
| ALT (U/L) | 25.5 ± 25.7 | 14.5 ± 11.5 | < 0.001 | 19.9 ± 9.8 | 11.5 ± 4.7 | < 0.001 | –11.0 ± 18.4 | –8.5 ± 8.4 | 0.425 |
| AST (U/L) | 22.1 ± 10.2 | 14.2 ± 6.5 | < 0.001 | 21.3 ± 5.7 | 12.8 ± 2.9 | < 0.001 | –7.9 ± 7.9 | –8.6 ± 5.4 | 0.647 |
| γ-GGT (U/L) | 44.6 ± 81.9 | 25.8 ± 45.5 | 0.004 | 27.8 ± 19.8 | 15.3 ± 10.2 | < 0.001 | –18.8 ± 39.9 | –12.5 ± 12.2 | 0.341 |
| Triglyceride (mg/dl) | 156.3 ± 86.0 | 97.5 ± 52.5 | < 0.001 | 159.2 ± 121.0 | 84.2 ± 57.4 | < 0.001 | –58.8 ± 84.7 | –75.0 ± 96.7 | 0.422 |
| HDL-cholesterol (mg/dl) | 49.7 ± 11.3 | 36.2 ± 12.2 | < 0.001 | 52.8 ± 12.1 | 35.6 ± 7.6 | < 0.001 | –13.5 ± 7.6 | –17.3 ± 10.0 | 0.060 |
| Fasting insulin (μIU/m) | 8.36 ± 6.6 | 8.25 ± 7.5 | 0.822 | 7.21 ± 4.0 | 6.20 ± 3.3 | 0.102 | –0.1 ± 3.0 | –1.0 ± 3.5 | 0.263 |
| Fasting glucose (mg/dl) | 86.7 ± 16.1 | 70.5 ± 11.8 | < 0.001 | 82.7 ± 20.9 | 68.4 ± 12.5 | < 0.001 | –16.2 ± 16.2 | –14.4 ± 17.9 | 0.622 |
| HOMA-IR | 33.4 ± 28.2 | 26.2 ± 27.2 | 0.004 | 28.3 ± 23.3 | 19.6 ± 12.8 | 0.012 | –6.8 ± 12.7 | –8.7 ± 19.0 | 0.634 |
BMI: body mass index; CT-scan: Computer tomography scan; HU: Hounsfield Unit; ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; γ-GGT; γ-glutamyl transferase; HDL-cholesterol: High density lipoprotein cholesterol; HOMA-IR: Homeostatic model assessment - insulin resistance (*p <0.05 by paired t test, **p <0.05 by Student t test).
Estimated sodium intake according to survey method
| Control diet (5 gram/day) | Low salt diet (2 gam/day) | |||||
|---|---|---|---|---|---|---|
| Baseline | 2 month | Baseline | 2 month | |||
| Total food intake (g) | 1488.1 ± 604.2 | 1314.9 ± 362.3 | 0.097 | 1510.6 ± 571 | 1289.2 ± 364 | 0.021 |
| Total energy intake (kcal) | 1971.6 ± 506.8 | 1445.5 ± 336.2 | < 0.001 | 1986.6 ± 690 | 1325.4 ± 219 | < 0.001 |
| Na intake, 3-day diary (g/day) | 4168.9 ± 1885.0 | 3508.4 ± 876.2 | 0.220 | 4150.1 ± 1734.3 | 1725.9±502.1 | < 0.001 |
| 24-HU Na excretion (mEq/day) | 172.5 ± 64.5 | 152.4 ± 67.6 | 0.056 | 186.9 ± 78.0 | 123.4 ± 49.6 | 0.001 |
Na: sodium; 24-HU Na excretion: 24-hours urine sodium excretion (*p <0.05 by Student t test between control and low salt group).
Figure 2Consort flow chat of randomized controlled study of low salt and control diet